Zaloguj się

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

13.6K Views

09:58 min

December 9th, 2016

DOI :

10.3791/54714-v

December 9th, 2016


Przeglądaj więcej filmów

RNA sequencing

Rozdziały w tym wideo

0:05

Title

1:09

Characterization of Drug Resistance Profiles through Cytotoxicity Assays

5:01

RNA Isolation and Library Preparation for RNA-sequencing

5:55

Validation of the Results by RT-PCR and qRT-PCR Assays

7:21

Results: Detection of Differential Splicing Events in Chemotherapy-resistant Cell Lines Compared to Parental Wild-type by Using RNA-sequencing

9:07

Conclusion

Powiązane Filmy

article

11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

14.8K Views

article

11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

16.7K Views

article

09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

33.4K Views

article

10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

4.7K Views

article

07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

919 Views

article

08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

2.6K Views

article

08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

10.5K Views

article

10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

10.5K Views

article

06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

588 Views

article

08:35

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data

5.4K Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone